examples of glp-1 receptor agonists for individualized treatment type 2 diabetes mellitus The anti-inflammatory and immunological properties
Description
However, questions remain about their long-term safety and efficacy
For each kilogram of peptide drug, dozens of kilograms of solvent waste may be produced
Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials
The patients must be encouraged to follow the specific recommendations to avoid/mitigate diarrhoea (Table 2, Figure 1, Figure 2 and Figure 3), which should already have been taught to them as part of their education prior to GLP-1 RA initiation
